Masimo Corp. Stock
Price
Target price
€146.60
€146.60
-0.280%
-0.4
-0.280%
€172.13
24.06.25 / Tradegate
WKN: 578074 / Symbol: MASI / Name: Masimo / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Masimo Corp. Stock
The price for the Masimo Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.400 (-0.280%).
With 16 Buy predictions and not the single Sell prediction the community is currently very high on Masimo Corp..
With a target price of 172 € there is a slightly positive potential of 17.33% for Masimo Corp. compared to the current price of 146.6 €.
Pros and Cons of Masimo Corp. in the next few years
Pros
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Masimo Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Masimo Corp. | -0.280% | 3.276% | 10.309% | 22.167% | -10.637% | 13.776% | -24.433% |
| Bio-Rad Labs Inc. A | 0.050% | 3.635% | 4.678% | -20.115% | -33.747% | -56.763% | -46.088% |
| Neogen Corp. | -0.980% | -15.638% | -23.364% | -72.667% | -65.833% | - | - |
| Haemonetics Corp. | 0.810% | 2.479% | 8.772% | -18.954% | -17.881% | 5.085% | -18.954% |
Comments
Masimo Co. (NASDAQ: MASI) had its price target lowered by analysts at Raymond James from $204.00 to $185.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
Masimo Co. (NASDAQ: MASI) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $200.00 price target on the stock, down previously from $215.00.
Show more
Ratings data for MASI provided by MarketBeat
Masimo Co. (NASDAQ: MASI) had its price target lowered by analysts at Wells Fargo & Company from $205.00 to $190.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for MASI provided by MarketBeat
News
Masimo Tops EPS, Revenue Expectations
Masimo (NASDAQ:MASI), a provider of noninvasive patient monitoring technology, released its fourth-quarter earnings for 2024, on Feb. 25, 2025. The results presented a mixed picture: strong
